Work

Selection of SAS-Tolerant Microorganisms from Activated Sludge and Assessment of Biodegradation Potential of SARS-CoV-2 Antivirals by Pure Bacterial Cultures and Activated Sludge

Year: 2025

Type: article

Abstract: The extensive use of antiviral substances (SASs) during and after the COVID-19 pandemic has increased their release into wastewater systems, raising concerns regarding their persistence and potential ecotoxicological effects. The primary objective of this study was to isolate bacterial strains from activated sludge (AS) that possess the ability to biodegrade SASs. From the AS sample, three bacterial species, Comamonas testosteroni (I2), Bacillus amyloliquefaciens (I3) and Bacillus mycoides (I4), were successfully isolated and identified. These strains were subsequently applied in biodegradation experiments targeting seven SASs: daclatasvir (DCV), darunavir (DRV), favipiravir (FAV), lopinavir (LOP), remdesivir (REM), ritonavir (RIT), and umifenovir (UMI). During the experiments, residual SAS concentrations, microbial growth parameters, physicochemical indicators and ecotoxicity were monitored. All three strains demonstrated substantial biodegradation potential, achieving reductions exceeding 90% for most tested compounds, with particularly low toxicity observed in experiments conducted with AS and Bacillus amyloliquefaciens. These findings highlight the relevance of AS-derived bacteria as promising candidates for enhancing SAS removal in wastewater treatment processes.

Source: Separations

DOI: 10.3390/separations13010003